You are viewing a single comment's thread from:

RE: LeoThread 2024-09-12 09:41

in LeoFinance2 months ago

While AlphaProteo has shown impressive results, it still faces challenges. For instance, it was unable to design a successful binder for TNFa, a protein associated with autoimmune diseases. However, this limitation is viewed as an opportunity for further improvement.

The technology's potential applications span various fields, including:

  • Drug discovery and development
  • Understanding and treating diseases
  • Enhancing crop resilience